Q3 2024 · 13F-HR
Valence8 US LPholdings as filed
Filed 2024-11-12 · accession 0001172661-24-004545
$241.1M
Reported value
62
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 46432F339 | QUAL | ISHARES TR | $60.5M | 25.1% | 337,472 | Common | SOLE |
| 46090E103 | QQQ | INVESCO QQQ TR | $43.0M | 17.8% | 88,149 | Common | SOLE |
| 46434V456 | IQLT | ISHARES TR | $42.6M | 17.7% | 1,026,290 | Common | SOLE |
| 464288877 | EFV | ISHARES TR | $23.0M | 9.53% | 399,186 | Common | SOLE |
| 922908744 | VTV | VANGUARD INDEX FDS | $16.9M | 7.00% | 96,630 | Common | SOLE |
| 81369Y308 | XLP | SELECT SECTOR SPDR TR | $13.7M | 5.69% | 165,267 | Common | SOLE |
| 46435G334 | EWU | ISHARES TR | $7.8M | 3.25% | 209,344 | Common | SOLE |
| 46434G822 | EWJ | ISHARES INC | $7.8M | 3.22% | 108,634 | Common | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $5.0M | 2.07% | 64,000 | CALL | SOLE |
| 81369Y886 | XLU | SELECT SECTOR SPDR TR | $4.2M | 1.74% | 51,940 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $999,236 | 0.41% | 8,969 | Common | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $920,196 | 0.38% | 17,785 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $684,586 | 0.28% | 4,585 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $644,420 | 0.27% | 2,000 | PUT | SOLE |
| 031162100 | AMGN | AMGEN INC | $644,420 | 0.27% | 2,000 | CALL | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $631,125 | 0.26% | 12,500 | CALL | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $615,438 | 0.26% | 13,100 | CALL | SOLE |
| 457669307 | INSM | INSMED INC | $574,145 | 0.24% | 7,865 | Common | SOLE |
| G4766E116 | INDV | INDIVIOR PLC | $564,186 | 0.23% | 57,293 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $560,800 | 0.23% | 633 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $516,602 | 0.21% | 953 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $490,056 | 0.20% | 9,706 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $481,800 | 0.20% | 6,600 | CALL | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $466,012 | 0.19% | 8,025 | Common | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $464,373 | 0.19% | 3,900 | CALL | SOLE |
| 670703107 | NUVL | NUVALENT INC | $420,965 | 0.17% | 4,115 | Common | SOLE |
| 14817C107 | FLNA | CASSAVA SCIENCES INC | $414,963 | 0.17% | 14,100 | PUT | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $383,295 | 0.16% | 6,900 | CALL | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $377,804 | 0.16% | 13,100 | CALL | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $356,944 | 0.15% | 7,857 | Common | SOLE |
| G29687103 | AVDL | AVADEL PHARMACEUTICALS PLC | $343,613 | 0.14% | 26,200 | CALL | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $341,552 | 0.14% | 6,684 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $310,050 | 0.13% | 13,188 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $307,798 | 0.13% | 5,240 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $298,025 | 0.12% | 13,100 | CALL | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $282,018 | 0.12% | 2,468 | Common | SOLE |
| 60770K107 | MRNA | MODERNA INC | $274,003 | 0.11% | 4,100 | CALL | SOLE |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $267,561 | 0.11% | 13,020 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $252,039 | 0.10% | 33,650 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $242,165 | 0.10% | 2,618 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $235,588 | 0.10% | 4,241 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $220,935 | 0.09% | 6,500 | PUT | SOLE |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $206,568 | 0.09% | 19,939 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $185,496 | 0.08% | 26,200 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $172,550 | 0.07% | 20,300 | CALL | SOLE |
| 02155H200 | ALT | ALTIMMUNE INC | $160,868 | 0.07% | 26,200 | CALL | SOLE |
| 488445206 | ZVRA | ZEVRA THERAPEUTICS INC | $149,876 | 0.06% | 21,596 | Common | SOLE |
| 02155H200 | ALT | ALTIMMUNE INC | $144,290 | 0.06% | 23,500 | PUT | SOLE |
| 29479A108 | ERAS | ERASCA INC | $128,100 | 0.05% | 46,923 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $123,009 | 0.05% | 13,100 | CALL | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $109,624 | 0.05% | 15,728 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $104,489 | 0.04% | 2,300 | PUT | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $103,472 | 0.04% | 34,376 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $99,560 | 0.04% | 13,100 | CALL | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $71,030 | 0.03% | 17,495 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $68,539 | 0.03% | 14,708 | Common | SOLE |
| 28658R106 | CLYM | ELIEM THERAPEUTICS INC | $61,309 | 0.03% | 12,045 | Common | SOLE |
| 12529R107 | CCCC | C4 THERAPEUTICS INC | $59,850 | 0.02% | 10,500 | CALL | SOLE |
| 52187K200 | CYPH | LEAP THERAPEUTICS INC | $47,573 | 0.02% | 18,511 | Common | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $33,939 | 0.01% | 26,107 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $20,418 | 0.01% | 20,700 | CALL | SOLE |
| 49372L100 | — | KEZAR LIFE SCIENCES INC | $16,342 | 0.01% | 21,136 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.